ACV meeting #23, 30 July 2021

The 23rd meeting of the Advisory Committee on Vaccines (ACV), July 2021.

Date

30 July 2021

The meeting of the Advisory Committee on Vaccines (ACV).

The committee provided advice on one application to register a new vaccine, and one application to extend the indications of the vaccine.

The committee provided advice on one matter relating to pharmacovigilance.

COVID-19 vaccine AstraZeneca [now, Vaxzevria] and Guillain Barre Syndrome

Members

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.

Outcomes

ACV meeting statement, Meeting 23, 30 July 2021

3 November 2021

Meeting statements

Advisory Committee on Vaccines meeting statement

Topics

Committees and advisory bodies

Meeting of

Advisory Committee on Vaccines (ACV)

Related content

Unique Device Identification (UDI) information session for clinical quality registries

25 May 2026

Webinars

This information session introduces UDI for clinical quality registries. Australia’s UDI framework supports improved identification of medical devices and in vitro diagnostic (IVD) devices.